U.S. Residential REITs Stock News

NasdaqGS:LASR
NasdaqGS:LASRElectronic

nLIGHT (LASR) Stock Still Looks Pricey Despite A 3 Year 3.6x Run

nLIGHT's share price has risen sharply over the past few years, yet its valuation checks currently lean expensive, which leaves investors weighing a strong share price record against a relatively weak value score. Over the past 3 years, nLIGHT has delivered a return of around 3.6x, which puts recent share price weakness into the context of a very strong longer term move. Expectations for nLIGHT's revenue growth and margin progression can support a higher valuation. However, any...
NasdaqGM:PSNL
NasdaqGM:PSNLLife Sciences

Personalis (PSNL) Reports Higher Sales And Wider Losses, Does The Stock Look Fully Valued?

How Personalis' latest earnings set the stage for investors Personalis (PSNL) released Q2 2026 results on 4 August, with sales of US$22.36 million and a net loss of US$31.68 million. This mix of higher revenue and wider loss is central to how investors may reassess the stock. For the first six months of 2026, Personalis reported sales of US$37.83 million and a net loss of US$61.72 million. Basic loss per share from continuing operations was US$0.59 for the period, including US$0.30 in Q2...
NYSE:RDDT
NYSE:RDDTInteractive Media and Services

Reddit (RDDT) Stock Looks Fairly Valued With Strong Earnings But Weak Broader Checks

Reddit stock has had a rough start to the year, with the share price down 34.4% year to date, while broader valuation checks suggest it does not clearly screen as cheap even after that pullback. The 34.4% year to date decline points to a sharp reset in expectations that investors now need to weigh against what they are paying for Reddit's future cash flows. Recent enthusiasm around AI driven advertising tools can support growth expectations, while uncertainty around search referral traffic...
NasdaqGS:JD
NasdaqGS:JDMultiline Retail

Why JD.com (JD) Is Back In The Spotlight

JD.com (JD) recently put its JINGDONG Cross-Border import platform in front of global beauty brands at Cosmoprof North America 2026, renewing investor attention on how its overseas merchant network ties into the core e commerce business. See our latest analysis for JD.com. JD.com’s recent visibility at Cosmoprof comes as the stock posts a 30 day share price return of 18.69% and a year to date share price return of 13.34%, while the 5 year total shareholder return is down 42.87%. Recent...
NYSE:EMR
NYSE:EMRElectrical

3 Global Blue Chip Dividend Stocks for AI Infrastructure Exposure

Global markets are being shaken by shifting economic policies and fresh signals from central banks, which is leaving many investors unsure about where to look next for reliable dividend income. Yet moments like this often separate temporary noise from long term opportunity. This article highlights 3 global blue chip dividend stocks that are closely tied to the recent news and explains why they might deserve a closer look if you care about income, resilience and staying invested with...
NYSE:TROX
NYSE:TROXChemicals

Tronox Holdings (TROX) Shares Just Moved, So What Is Behind The Attention?

Tronox Holdings (NYSE:TROX) is back in focus after second quarter 2026 results showed higher titanium dioxide and zircon volumes alongside year over year revenue growth, yet a wider net loss driven largely by a deferred tax valuation allowance. See our latest analysis for Tronox Holdings. At a share price of $6.22, Tronox Holdings has seen a year to date share price return of 45.67%, while the 1 year total shareholder return of 104.59% contrasts with weaker 3 and 5 year total shareholder...
NasdaqGS:SHOO
NasdaqGS:SHOOLuxury

Return To Profit And Higher 2026 Outlook Could Be A Game Changer For Steven Madden (SHOO)

Steven Madden, Ltd. reported past second-quarter 2026 results showing revenue of US$665.87 million and net income of US$27.73 million, a shift from a net loss a year earlier, while also affirming quarterly dividends and updating full-year 2026 guidance. The company’s move from loss to profit, alongside higher revenue expectations for 2026, suggests its product mix and cost structure have recently become more effective. Next, we’ll examine how this earnings improvement and upgraded 2026...
NYSE:DBRG
NYSE:DBRGCapital Markets

DigitalBridge Stock Leads 3 Alternative Asset Managers Tied To The AI Data Center Boom

Nvidia’s move to secure US$500b for AI data centres has turned compute infrastructure into a headline asset class and put global alternative asset managers firmly in the spotlight. Capital is flowing toward firms that can source, structure, and deploy money into this AI build out. This article looks at 3 stocks from our Global Alternative Asset Managers screener that are closely linked to this trend and explains why their AI exposure may be relevant for investors. The stocks covered below are...
NYSE:DMC
NYSE:DMCFood

Del Monte (DMC) Could Be 42% Undervalued Following Weaker Earnings And A Steady Dividend

Dividend and earnings announcement put Del Monte in focus Del Monte (DMC) drew fresh attention after reporting second quarter and half year results that showed lower profitability alongside relatively steady sales, while also declaring a quarterly dividend of $0.30 per share. See our latest analysis for Del Monte. The earnings release and dividend decision appear to be landing in a mixed sentiment period for Del Monte, with the share price up 6.96% over 30 days but down 14.68% over 90 days...
NasdaqGS:GPRE
NasdaqGS:GPREOil and Gas

Can Green Plains (GPRE) Sustain Its New Profitability Profile With Lower Ethanol Production Volumes?

In the second quarter of 2026, Green Plains Inc. reported sales of US$446.22 million, net income of US$67.15 million and diluted earnings per share from continuing operations of US$0.83, alongside lower ethanol and coproduct production versus a year earlier. The shift from a loss to profit despite reduced volumes suggests that cost management and operational efficiencies had a meaningful effect on Green Plains’ profitability profile in the period. We’ll now examine how this profitability...
NYSE:BF.B
NYSE:BF.BBeverage

How Valuation Gaps Amid Softer Spirits Demand Will Impact Brown-Forman (BF.B) Investors

In recent weeks, Brown-Forman has attracted renewed investor attention as analysts highlight mixed valuation signals, with cash-flow-based models implying the shares may be trading below intrinsic value while earnings multiples point closer to fair value. This tension between perceived undervaluation and ongoing pressure from softer spirits demand and higher input costs is increasingly shaping how investors assess Brown-Forman’s long-term prospects. Next, we’ll examine how this focus on...
NasdaqGS:EBAY
NasdaqGS:EBAYMultiline Retail

eBay (EBAY) Stock May Be 29% Undervalued Despite Raised Outlook

eBay stock has delivered a very strong 157.8% return over the past three years, yet current valuation checks send a mixed message, with a Discounted Cash Flow (DCF) estimate pointing to meaningful upside while market based multiples look closer to fairly priced. Over the last three years, eBay has returned 157.8%, which puts extra focus on whether today’s price still leaves enough room above intrinsic value. Recent growth in luxury resale, collectibles and apparel, helped by AI powered...
NYSE:SQM
NYSE:SQMChemicals

Sociedad Química y Minera de Chile (SQM) Is Up 8.7% After Doubling Mt Holland Lithium Output Plan

Sociedad Química y Minera de Chile S.A. and Wesfarmers have approved expanding the Mt Holland lithium project in Australia, aiming to double annual spodumene concentrate output to about 760,000 tonnes and add a new ore sorting facility, with SQM expecting to invest roughly US$450 million to US$500 million. The expansion gives SQM more flexibility to either feed any future increase in downstream processing at the Kwinana refinery or sell higher volumes of concentrate directly into the lithium...
NasdaqGS:NXPI
NasdaqGS:NXPISemiconductor

3 US Earnings Growth Stocks Riding The AI Capex Boom

AI related spending now accounts for a large share of US$1.5 trillion in expected S&P 500 capex and corporate earnings are reported up 32%, which helps explain why JPMorgan recently lifted its S&P 500 target to 8,000. That kind of backdrop can quickly reward or punish companies exposed to this surge. This article walks through three US stocks from our earnings growth screener that appear tightly linked to these trends. The three stocks below are just a starting sample from this earnings...
NYSE:XPO
NYSE:XPOTransportation

XPO Stock And 2 US Logistics Names Tied To Fuel Route Shifts

With the Iran conflict straining global oil flows and the Jones Act waiver reshaping how fuel moves between U.S. ports, domestic infrastructure and logistics stocks suddenly sit closer to the action than many investors expected. Supply chains are being rerouted, costs are shifting and some companies could see fresh demand while others face new pressure. This article spotlights 3 stocks exposed to these crosscurrents and explains what their roles might mean for your portfolio. The three...
NasdaqCM:UROY
NasdaqCM:UROYMetals and Mining

Uranium Royalty (UROY), Why Is It Back In The Spotlight?

Recent board changes at Uranium Royalty (NasdaqCM:UROY) have put governance in focus after a busy few weeks that also included fresh annual results, a new shelf registration, and a voluntary SEC deregistration. See our latest analysis for Uranium Royalty. Against this backdrop of board changes, annual results and new capital plans, Uranium Royalty’s share price has moved sharply in recent weeks, with a 30 day share price return of 50.18% and a 1 year total shareholder return of 60.70%, which...
NYSE:HOG
NYSE:HOGAuto

Is Soft Core Demand and Cash Flow Pressure Reshaping Harley-Davidson’s Brand-First Strategy (HOG)?

Tilley Harley-Davidson previously hosted its Freedom Revival, a 1970s-themed classic motorcycle show at its Statesville, North Carolina dealership, showcasing vintage Shovelhead and Ironhead models alongside highlighted pre-owned CVO Street Glide bikes. At the same time, Harley-Davidson’s relatively low motorcycle sales and weak free cash flow margin have drawn attention to underlying operational and financial strains. We’ll now examine how softer core motorcycle demand, and the resulting...
NYSE:XHR
NYSE:XHRHotel and Resort REITs

What’s Behind Xenia Hotels & Resorts (XHR) Stock’s Latest Move?

Equity offering and shelf registration reshape the picture for Xenia Hotels & Resorts stock Xenia Hotels & Resorts (XHR) has just completed a US$136.9 million at the market common stock offering and filed a new US$200 million shelf registration. This provides the company with fresh funding capacity that investors will likely watch closely. See our latest analysis for Xenia Hotels & Resorts. Despite a recent pullback, with a 7 day share price return of down 7.9% and a 30 day share price return...
NYSE:NGVT
NYSE:NGVTChemicals

Does Profitability Swing And Buybacks Shift The Bull Case For Ingevity (NGVT)?

Ingevity Corporation reported past second-quarter 2026 results with sales of US$314.1 million, net income of US$35.3 million, and diluted earnings per share from continuing operations of US$1.13, alongside ongoing progress on portfolio reshaping and a completed share repurchase of 493,375 shares for US$35 million under its 2022 buyback program. The shift from a prior-year loss to profitability, combined with higher full-year adjusted EBITDA and EPS guidance, highlights management’s...
NasdaqGS:VISN
NasdaqGS:VISNCommunications

Vistance Networks (VISN) On Special Payout And Earnings Is The Stock Now Fully Valued

Vistance Networks (VISN) has drawn fresh attention after reporting second quarter earnings along with a special $5.00 per share cash distribution, a combination that puts both recent profit trends and capital returns in focus for shareholders. See our latest analysis for Vistance Networks. Alongside the stronger earnings and the special distribution, Vistance Networks has seen mixed share price momentum, with the share price down 37.46% year to date but a very large 3 year total shareholder...
NYSE:UTI
NYSE:UTIConsumer Services

Should Universal Technical Institute (UTI) Revisit Its Valuation After Cutting Fiscal 2026 Guidance?

Universal Technical Institute (UTI) is back in focus after its latest earnings update, which combined higher third quarter revenue and new student starts with a reduced fiscal 2026 outlook tied to enrollment mix and guidance revisions. See our latest analysis for Universal Technical Institute. The earnings update and lowered fiscal 2026 guidance have clearly shifted sentiment, with Universal Technical Institute’s share price falling 35.33% over the past week and 44.85% over the past month,...
NasdaqGS:CHEF
NasdaqGS:CHEFConsumer Retailing

3 U.S. Stocks With Domestic Supply Chains as Tariffs Reshape Investor Focus

With fresh tariffs on 60 key U.S. trading partners drawing a hard line on forced labor, the spotlight has swung to companies that rely more on domestic supply chains than global ones. This shift could reshape where risks and potential opportunities sit in your portfolio, especially as costs and inflation pressures ripple through. This article walks through three U.S.-focused stocks exposed to the tariff story and explains why they may warrant closer attention now. The three stocks covered...
NYSE:BNY
NYSE:BNYCapital Markets

Bank of New York Mellon Corporation (BNY) Could Be 4% Undervalued Following Its Digital Asset Push

Why Bank of New York Mellon Corporation Stock Is Back in Focus Bank of New York Mellon Corporation (BNY) is back on investors’ radar after fresh moves in digital assets, including a new staking partnership with Galaxy Digital and the rollout of tokenized fund and transfer agency capabilities. See our latest analysis for Bank of New York Mellon. Alongside these digital asset moves, the BNY share price has been firm, with a 1-month share price return of 4.94% and a 90-day share price return of...
NasdaqCM:MLTX
NasdaqCM:MLTXBiotechs

How Psoriatic Arthritis Trial Success and Q2 Losses Could Shape MoonLake Immunotherapeutics (MLTX) Investors

MoonLake Immunotherapeutics reported second-quarter 2026 results, posting a net loss of US$61.81 million (US$0.84 basic loss per share) and announcing that its Phase 3 IZAR-1 trial of sonelokimab in biologic-naïve adults with active psoriatic arthritis met all clinical endpoints at Week 16. The trial’s topline data showed clinically meaningful improvements across joint, skin and quality-of-life measures, reinforcing sonelokimab’s potential to address multiple manifestations of psoriatic...